Health Care & Life Sciences » Biotechnology | LegoChem Biosciences Inc.

LegoChem Biosciences Inc.

LegoChem Biosciences Inc.
Stock Exchange Korea Exchange
EPS
KRW1049
Market Cap
KRW450.6 B
Shares Outstanding
10.59 M
Public Float
7.8 M

Profile

Address
8-26 Munpyeongseo-ro
Daejeon DE 34302
Korea, Republic Of
Employees -
Website http://www.legochembio.com
Updated 09/14/2018
LegoChem Biosciences, Inc. engages in the development and manufacturing of pharmaceuticals. Its main therapeutic areas include antibiotics, anti-coagulants, oncology, antibody-drug conjugate and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, South Korea.

Financials

View All
Created with Highcharts 5.0.14LegoChem Biosciences Inc.Net Income. Fiscal year is January-December. All values KRW Millions.5 8355 8358 6868 6868 2378 23714 72514 72512 93412 9342013201420152016201702.5k5k7.5k10k12.5k15k17.5k
Created with Highcharts 5.0.14LegoChem Biosciences Inc.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.8408408708701 7881 78816 65516 65522 05722 0572013201420152016201705k10k15k20k25k

Yong-Zu Kim
Chief Executive Officer & Director
Beop-Pyo Lee
Director, Vice President, Head-Medicine